Want to see IN:SHALBY full AI Analyst Report?

Shalby Ltd. (SHALBY) Price & Analysis

0 Followers

SHALBY Stock Chart & Stats

₹162.45

-₹1.58(-0.97%)

At close: Jul 30 4:00 PM EDT

₹162.45

-₹1.58(-0.97%)

Day’s Range― - ―

52-Week Range₹125.70 - ₹274.50

Previous CloseN/A

Volume41.00K

Average Volume (3M)71.31K

Market Cap

₹16.70B

Enterprise Value₹18.58K

Total Cash (Recent Filing)₹841.97M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)43.7

Beta1.13

Next Earnings

Oct 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)3.54

Shares Outstanding108,009,766

10 Day Avg. Volume22,132

30 Day Avg. Volume71,313

Financial Highlights & Ratios

PEG Ratio0.09

Price to Book (P/B)1.46

Price to Sales (P/S)1.29

P/FCF Ratio-8.05

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.4

Revenue Forecast (FY)₹12.11B

Bulls Say, Bears Say

Bulls Say

Strong Long-term Revenue ExpansionThe substantial multi-year increase in revenue indicates expanding patient volumes, service capacity or case complexity. Continued top-line growth provides a durable platform for operating leverage if Shalby can improve utilization, pricing and clinical mix.

Specialized Hospital Services PlatformA hospital network anchored by orthopedic and joint-replacement expertise, while offering broader tertiary and quaternary care, supports multiple patient needs. This model can strengthen referral relationships and diversify revenue across inpatient and outpatient services.

Reasonable Equity Capital CushionStable equity provides a meaningful capital base for hospital operations and future investment, even as leverage has increased. This cushion may help Shalby absorb execution volatility and fund capacity or service development without relying entirely on new borrowing.

Bears Say

Persistent Negative Cash GenerationNegative operating and free cash flow indicate that reported growth is not currently converting into internally generated funds. Persistent cash consumption can restrict reinvestment, increase dependence on financing and elevate execution risk across the hospital network.

Rising Leverage And Weaker Capital EfficiencyHigher leverage increases fixed financial obligations while the low return on equity suggests capital is being used less efficiently. Together, these trends reduce financial flexibility and make future expansion more sensitive to operating performance and funding costs.

Margin Compression And Earnings VolatilityMargin erosion means revenue growth is producing less bottom-line benefit than in earlier years. Lower profitability reduces resilience to staffing, implant, consumable and operating-cost pressures, making sustainable earnings growth dependent on operational improvement.

Shalby Ltd. News

Shalby Medtech CEO Deepak Anand to Step Down in September

Shalby Ltd. ( ($IN:SHALBY) ) has shared an update. Shalby Limited has announced that Mr. Deepak Anand will...

12d ago

Shalby Employee Exercises Stock Options With No Change to Share Capital

The latest update is out from Shalby Ltd. ( ($IN:SHALBY) ). Shalby Ltd. has reported that an eligible...

4M ago

Shalby Faces Rs 4.14 Crore Tax Demand After ITAT Ruling

Shalby Ltd. ( ($IN:SHALBY) ) has provided an update. Shalby Limited has disclosed that the Income Tax Appellate...

5M ago

Shalby’s Krishna Unit Wins Five-Year Approval for Kidney Transplants

The latest announcement is out from Shalby Ltd. ( ($IN:SHALBY) ). Shalby Limited has announced that its Krishna...

5M ago

Shalby Subsidiary Hospital in Gurugram Secures NABH 6th Edition Accreditation

Shalby Ltd. ( ($IN:SHALBY) ) has issued an announcement. Shalby Limited has announced that its subsidiary PK Healthcare...

6M ago

Shalby Files SEBI Regulation 74(5) Compliance Certificate for December Quarter

An announcement from Shalby Ltd. ( ($IN:SHALBY) ) is now available. Shalby Limited has filed a confirmation certificate...

8M ago

Shalby Reports Nil Physical Share Transfer Re‑lodgement Requests for December 2025

The latest announcement is out from Shalby Ltd. ( ($IN:SHALBY) ). Shalby Limited has reported to the NSE...

8M ago

Shalby Limited Reports No Activity in Physical Share Transfers

Shalby Ltd. ( ($IN:SHALBY) ) has issued an announcement. Shalby Limited has submitted a report to the National...

10M ago

SHALBY FAQ

What was Shalby Ltd.’s price range in the past 12 months?

Shalby Ltd. lowest stock price was ₹125.70 and its highest was ₹274.50 in the past 12 months.

What is Shalby Ltd.’s market cap?

Shalby Ltd.’s market cap is ₹16.70B.

When is Shalby Ltd.’s upcoming earnings report date?

Shalby Ltd.’s upcoming earnings report date is Oct 22, 2026 which is in 53 days.

How were Shalby Ltd.’s earnings last quarter?

Shalby Ltd. released its earnings results on Aug 12, 2026. The company reported ₹1.016 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Shalby Ltd. overvalued?

According to Wall Street analysts Shalby Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shalby Ltd. pay dividends?

Shalby Ltd. pays a Annually dividend of ₹1.2 which represents an annual dividend yield of N/A. See more information on Shalby Ltd. dividends here

What is Shalby Ltd.’s EPS estimate?

Shalby Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shalby Ltd. have?

Shalby Ltd. has 108,009,766 shares outstanding.

What happened to Shalby Ltd.’s price movement after its last earnings report?

Shalby Ltd. reported an EPS of ₹1.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.907%.

Which hedge fund is a major shareholder of Shalby Ltd.?

Currently, no hedge funds are holding shares in IN:SHALBY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shalby Ltd.

Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.